US
Ulhas Shivajirao Gapat
About Ulhas Shivajirao Gapat
Ulhas Shivajirao Gapat has 14 years in corporate governance. Holds Additional Director and Designated Partner roles. Currently with 2 companies, including Mavp Projects India Private Limited and Medrevo Life Sciences Llp. Formerly with 1 company, such as Aarohan Technocrats Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Mavp Projects India Private Limited
U45309PN2017PTC169162
|
Additional Director | 01 Sep 2017 | 2017 | Active |
|
Medrevo Life Sciences Llp
ACB-1054
|
Designated Partner | 11 May 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Aarohan Technocrats Private Limited
U31401PN2012PTC142695
|
Director | 27 Mar 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ulhas Shivajirao Gapat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ulhas Shivajirao Gapat
Ulhas Shivajirao Gapat has 14 years in corporate governance. Holds Additional Director and Designated Partner roles. Currently with 2 companies, including Mavp Projects India Private Limited and Medrevo Life Sciences Llp. Formerly with 1 company, such as Aarohan Technocrats Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Ulhas Shivajirao Gapat is associated with 2 companies as Additional Director and Designated Partner.
Ulhas Shivajirao Gapat has expertise in General Business, Technology.
Ulhas Shivajirao Gapat has 14 years in corporate governance.